CompletedNCT02703363
Minocycline and Celecoxib Added for Bipolar Depression
About this title
Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression
Read the official source — NCT02703363Medication studyAges 18–65PakistanBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Karachi and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: August 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 265
- Sponsor
- Pakistan Institute of Living and Learning
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Pakistan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02703363
- Official title
Show the full official title
Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression: A Factorial Design Randomised Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Karachi
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pakistan Institute of Living and Learning, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Minocycline, Celecoxib and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
